NDC 55513-112 – Tezspire

Tezepelumab 210 mg/1.9mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC55513-112

Product details

Brand name
Tezspire
Generic name
Tezepelumab-ekko
Labeler
Amgen Inc
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761224
Marketed since
December 17, 2021
Listing expires
December 31, 2027
Pharmacologic class
Thymic Stromal Lymphopoietin Blocker

Active ingredients

Uses, dosage, side effects and warnings for Tezspire →

Package NDC codes (2)

Package NDCDescriptionSince
55513-112-011 SYRINGE in 1 CARTON (55513-112-01) / 1.91 mL in 1 SYRINGEDec 17, 2021
55513-112-96 sample1 SYRINGE in 1 CARTON (55513-112-96) / 1.91 mL in 1 SYRINGEDec 17, 2021

Other Tezspire products